<DOC>
	<DOCNO>NCT00197808</DOCNO>
	<brief_summary>The purpose study evaluate immune response UK infants one two dos pneumococcal conjugate vaccine one two dos three different type meningococcal conjugate vaccine give either two three two four month age .</brief_summary>
	<brief_title>Response United Kingdom ( UK ) Infants Reduced Primary Schedule With Meningococcal C Pneumococcal Conjugate Vaccines</brief_title>
	<detailed_description />
	<mesh_term>Infection</mesh_term>
	<mesh_term>Communicable Diseases</mesh_term>
	<mesh_term>Pneumococcal Infections</mesh_term>
	<mesh_term>Meningococcal Infections</mesh_term>
	<mesh_term>Vaccines</mesh_term>
	<mesh_term>Heptavalent Pneumococcal Conjugate Vaccine</mesh_term>
	<criteria>Written inform consent obtain parent legal guardian infant Age 711 week first dose Any contraindication vaccination specify UK Handbook `` Immunisation Against Infectious Disease '' ( Ed 1996 ) &lt; 7 week &gt; 11 week first dose</criteria>
	<gender>All</gender>
	<minimum_age>7 Weeks</minimum_age>
	<maximum_age>11 Weeks</maximum_age>
	<verification_date>March 2012</verification_date>
	<keyword>Streptococcus pneumoniae</keyword>
	<keyword>Neisseria meningitidis</keyword>
</DOC>